haloperidol and exp3174

haloperidol has been researched along with exp3174 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benachour, N; Vanderheyden, PML1
Prusty, S; Sahu, PK; Singh, VK; Subudhi, BB1

Reviews

1 review(s) available for haloperidol and exp3174

ArticleYear
Influence of the cellular environment on ligand binding kinetics at membrane-bound targets.
    Bioorganic & medicinal chemistry letters, 2017, 08-15, Volume: 27, Issue:16

    Topics: Angiotensin II Type 1 Receptor Blockers; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Humans; Kinetics; Ligands; Protein Binding; Receptor, Angiotensin, Type 1; Receptors, Cell Surface; Signal Transduction

2017

Other Studies

1 other study(ies) available for haloperidol and exp3174

ArticleYear
Conjugation to Ascorbic Acid Enhances Brain Availability of Losartan Carboxylic Acid and Protects Against Parkinsonism in Rats.
    The AAPS journal, 2018, 10-22, Volume: 20, Issue:6

    Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Ascorbic Acid; Behavior, Animal; Biological Availability; Brain; Disease Models, Animal; Drug Evaluation, Preclinical; Haloperidol; Humans; Losartan; Male; Parkinsonian Disorders; Rats; Rats, Wistar; Renin-Angiotensin System

2018